SYNAPTICURE Trademark

Trademark Overview


On Thursday, September 17, 2020, a trademark application was filed for SYNAPTICURE with the United States Patent and Trademark Office. The USPTO has given the SYNAPTICURE trademark a serial number of 90188939. The federal status of this trademark filing is REGISTERED as of Tuesday, April 12, 2022. This trademark is owned by SynaptiCure, Inc.. The SYNAPTICURE trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Referrals in the field of neurodegenerative medicine, namely, doctor and clinical trial referral services to patients with neurodegenerative diseases

Providing telehealth in the nature of telemedicine services and health-care-consulting in the field of neurodegenerative disease; maintaining patient medical records electronically; genetic testing for medical purposes, namely, providing disease and genetic analysis services to patients by screening therapies best suited for individual patients through use of proprietary models

Providing medical research information in the nature of sharing data sets containing patient data for neurodegenerative-disease research purposes
synapticure

General Information


Serial Number90188939
Word MarkSYNAPTICURE
Filing DateThursday, September 17, 2020
Status700 - REGISTERED
Status DateTuesday, April 12, 2022
Registration Number6702483
Registration DateTuesday, April 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements


Goods and ServicesReferrals in the field of neurodegenerative medicine, namely, doctor and clinical trial referral services to patients with neurodegenerative diseases
Goods and ServicesProviding telehealth in the nature of telemedicine services and health-care-consulting in the field of neurodegenerative disease; maintaining patient medical records electronically; genetic testing for medical purposes, namely, providing disease and genetic analysis services to patients by screening therapies best suited for individual patients through use of proprietary models
Goods and ServicesProviding medical research information in the nature of sharing data sets containing patient data for neurodegenerative-disease research purposes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, June 3, 2021
Primary Code035
First Use Anywhere DateTuesday, February 1, 2022
First Use In Commerce DateTuesday, February 1, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 3, 2021
Primary Code042
First Use Anywhere DateTuesday, February 1, 2022
First Use In Commerce DateTuesday, February 1, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 26, 2020
Primary Code044
First Use Anywhere DateTuesday, February 1, 2022
First Use In Commerce DateTuesday, February 1, 2022

Trademark Owner History


Party NameSynaptiCure, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChicago, IL 60614

Party NameSynaptiCure, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60614

Party NameSynaptiCure, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60614

Trademark Events


Event DateEvent Description
Tuesday, April 12, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, March 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 3, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 8, 2022USE AMENDMENT FILED
Wednesday, March 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 8, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, September 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 5, 2021NON-FINAL ACTION E-MAILED
Friday, February 5, 2021NON-FINAL ACTION WRITTEN
Monday, February 1, 2021ASSIGNED TO EXAMINER
Monday, October 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 21, 2020NEW APPLICATION ENTERED IN TRAM